IP Library › Granted Patent US 12,324,918
Granted Patent B2
US 12,324,918 · App. 18/464,902 · Granted Jun 10, 2025

Methods and systems for lead movement detection and response in DBS therapy

Inventors: G. Karl Steinke (Valencia, CA); Manoj Vasantharaj (Valencia, CA); Raul Enrique Serrano Carmona (Venice, CA); Mahsa Malekmohammadi (Sherman Oaks, CA)
Assignee: Boston Scientific Neuromodulation Corporation
A61N1/3614A61N1/0534
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 12,324,918
App. No.
18/464,902
Granted
Jun 10, 2025
Kind
B2
Abstract

Methods and systems for detecting if a stimulation lead implanted in a patient's brain has moved. Lead movement occurring between a first time and a second time may be determined by comparing features extracted from evoked potentials recorded at the two times. The disclosed methods and systems are particularly useful for determining if a stimulation lead has moved between the time it was implanted in the patient's brain and the time that stimulation parameters are being optimized. Lead movement during implantation, during parameter optimization, and during or between other lead optimization processes may be determined as well.

Claims (33)

1. A method of programming stimulation for deep brain stimulation (DBS) to treat Parkinson's Disease (PD) in a patient having one or more electrode leads implantable in their brain, wherein each electrode lead comprises a plurality of electrode contacts, the method comprising:

receiving parameters specifying (1) a first stimulation location on the lead, and (2) a first one or more values for one or more features extracted from recorded first evoked potentials (EPs) evoked by stimulation at the first stimulation location, wherein the first stimulation location and the first one or more values were previously determined when the lead was implanted in the patient's brain,

providing a second stimulation to the patient's brain using the first stimulation location upon the lead,

recording second EPs evoked by the second stimulation,

extracting second one or more values for the one or more features of the second EPs,

comparing the first and second one or more values to determine whether to use the first stimulation location as an input for a lead optimization to program stimulation for the patient,

if it is determined to use the first stimulation location, inputting the first stimulation location into the lead optimization program,

if it is determined not to use the first stimulation location, inputting an alternative stimulation location into the lead optimization program,

using the lead optimization program to optimize therapeutic stimulation, wherein the therapeutic stimulation is configured to treat PD, and

providing the optimized stimulation to the patient.

2. The method of claim 1 , wherein comparing the first and second one or more values comprises determining a difference between the first and second one or more values and comparing the difference to a predetermined threshold value.

3. The method of claim 2 , further comprising causing a user interface to display an indication that the lead has moved if the difference exceeds the threshold value.

4. The method of claim 3 , further comprising using the indication that the lead has moved to determine whether to use the first stimulation location as an input for a lead optimization algorithm.

5. The method of claim 4 , comprising determining not to use the first stimulation location as an input for a lead optimization algorithm if the difference exceeds the threshold value.

6. The method of claim 1 , further comprising determining if the lead has moved longitudinally.

7. The method of claim 1 , further comprising determining if the lead has rotated.

8. A system for programming stimulation for deep brain stimulation (DBS) to treat Parkinson's Disease (PD) in a patient having one or more electrode leads implantable in their brain, wherein each electrode lead comprises a plurality of electrode contacts, the system comprising:

control circuitry configured to execute a method comprising:

receiving parameters specifying (1) a first stimulation location on the lead, and (2) a first one or more values for one or more features extracted from recorded first evoked potentials (EPs) evoked by stimulation at the first stimulation location, wherein the first stimulation location and the first one or more values were previously determined when the lead was implanted in the patient's brain,

providing a second stimulation to the patient using the first stimulation location upon the lead,

recording second EPs evoked by the second stimulation,

extracting second one or more values for the one or more features of the second EPs,

comparing the first and second one or more values to determine whether to use the first stimulation location as an input for a lead optimization to program stimulation for the patient

if it is determined to use the first stimulation location, inputting the first stimulation location into the lead optimization program,

if it is determined not to use the first stimulation location, inputting an alternative stimulation location into the lead optimization program,

using the lead optimization program to optimize therapeutic stimulation, wherein the therapeutic stimulation is configured to treat PD, and

providing the optimized stimulation to the patient.

9. The system of claim 8 , wherein comparing the first and second one or more values comprises determining a difference between the first and second one or more values and comparing the difference to a predetermined threshold value.

10. The system of claim 9 , wherein the method further comprises causing a user interface to display an indication that the lead has moved if the difference exceeds the threshold value.

11. The system of claim 9 , wherein the method further comprises using the indication that the lead has moved to determine whether to use the first stimulation location as an input for a lead optimization algorithm.

12. The system of claim 11 , comprising determining not to use the first stimulation location as an input for a lead optimization algorithm if the difference exceeds the threshold value.

13. The system of claim 8 , wherein determining if the lead has moved comprises determining if the lead has moved longitudinally.

14. The method of claim 8 , wherein determining if the lead has moved comprises determining if the lead has rotated.

Continuity (4)
Continuation 17653816 · Mar 7, 2022
Provisional Application 63263634 · Nov 5, 2021
Provisional Application 63162887 · Mar 18, 2021
Related Publication 20230414948A1 · Dec 28, 2023
References Cited (194)
US 6052624A · Mann · 2000 [cited by applicant]
US 6181969B1 · Gord · 2001 [cited by applicant]
US 6393325B1 · Mann et al. · 2002 [cited by applicant]
US 6490486B1 · Bradley · 2002 [cited by applicant]
US 6609032B1 · Woods et al. · 2003 [cited by applicant]
US 6845267B2 · Harrison et al. · 2005 [cited by applicant]
US 6909917B2 · Woods et al. · 2005 [cited by applicant]
US 6950707B2 · Whitehurst · 2005 [cited by applicant]
US 7555346B1 · Woods et al. · 2009 [cited by applicant]
US 7582062B2 · Magill et al. · 2009 [cited by applicant]
US 7831307B1 · Moffitt · 2010 [cited by applicant]
US 7930030B2 · Woods et al. · 2011 [cited by applicant]
US 8121701B2 · Woods et al. · 2012 [cited by applicant]
US 8180601B2 · Butson et al. · 2012 [cited by applicant]
US 8265762B2 · Woods et al. · 2012 [cited by applicant]
US 8401658B2 · Woods et al. · 2013 [cited by applicant]
US 8606362B2 · He et al. · 2013 [cited by applicant]
US 8620436B2 · Parramon et al. · 2013 [cited by applicant]
US 8805524B2 · Woods et al. · 2014 [cited by applicant]
US 8812124B2 · Lee · 2014 [cited by applicant]
US 8855773B2 · Kokones et al. · 2014 [cited by applicant]
US 8868193B2 · Ranu et al. · 2014 [cited by applicant]
US 8868196B2 · Lee et al. · 2014 [cited by applicant]
US 8868197B2 · Lee · 2014 [cited by applicant]
US 8909350B2 · Lee · 2014 [cited by applicant]
US 8914119B2 · Wu et al. · 2014 [cited by applicant]
US 8958615B2 · Blum et al. · 2015 [cited by applicant]
US 9014820B2 · Lee et al. · 2015 [cited by applicant]
US 9050473B2 · Woods et al. · 2015 [cited by applicant]
US 9072905B2 · Kokones et al. · 2015 [cited by applicant]
US 9205261B2 · Kim et al. · 2015 [cited by applicant]
US 9248280B2 · Moffitt et al. · 2016 [cited by applicant]
US 9381356B2 · Parker et al. · 2016 [cited by applicant]
US 9387328B2 · Lee · 2016 [cited by applicant]
US 9387334B2 · Lee et al. · 2016 [cited by applicant]
US 9411935B2 · Moffitt et al. · 2016 [cited by applicant]
US 9511231B1 · Kent et al. · 2016 [cited by applicant]
US 10183167B2 · Steinke et al. · 2019 [cited by applicant]
US 10183168B2 · Baru et al. · 2019 [cited by applicant]
US 10195439B2 · Steinke et al. · 2019 [cited by applicant]
US 10207113B2 · Lee et al. · 2019 [cited by applicant]
US 10207114B2 · Lee · 2019 [cited by applicant]
US 10249041B2 · Varkuti · 2019 [cited by applicant]
US 10252059B2 · Steinke et al. · 2019 [cited by applicant]
US 10286205B2 · Steinke et al. · 2019 [cited by applicant]
US 10406368B2 · Hershey et al. · 2019 [cited by applicant]
US 10463860B2 · Sinclair et al. · 2019 [cited by applicant]
US 10549097B2 · Zhang et al. · 2020 [cited by applicant]
US 10576292B2 · Orinski · 2020 [cited by applicant]
US 10974051B2 · Steinke et al. · 2021 [cited by applicant]
US 10994131B2 · Durand et al. · 2021 [cited by applicant]
US 11020004B2 · Varkuti · 2021 [cited by applicant]
US 11123563B2 · Mustakos et al. · 2021 [cited by applicant]
US 11195609B2 · Mustakos et al. · 2021 [cited by applicant]
US 11344732B2 · Moffitt et al. · 2022 [cited by applicant]
US 11376433B2 · Zhang et al. · 2022 [cited by applicant]
US 11478633B2 · Tinkhauser et al. · 2022 [cited by applicant]
US 20050065427A1 · Magill et al. · 2005 [cited by applicant]
US 20060224222A1 · Bradley · 2006 [cited by examiner]
US 20070244407A1 · Osorio · 2007 [cited by applicant]
US 20090118786A1 · Meadows et al. · 2009 [cited by applicant]
US 20090118787A1 · Moffitt et al. · 2009 [cited by applicant]
US 20090299421A1 · Sawchuk · 2009 [cited by applicant]
US 20100305660A1 · Hegi et al. · 2010 [cited by applicant]
US 20110105939A1 · Yong et al. · 2011 [cited by applicant]
US 20120046712A1 · Woods et al. · 2012 [cited by applicant]
US 20120092031A1 · Shi et al. · 2012 [cited by applicant]
US 20120095519A1 · Parramon et al. · 2012 [cited by applicant]
US 20120095529A1 · Parramon et al. · 2012 [cited by applicant]
US 20130289665A1 · Marnfeldt et al. · 2013 [cited by applicant]
US 20140163639A1 · Zhu · 2014 [cited by applicant]
US 20140243926A1 · Carcieri · 2014 [cited by applicant]
US 20140277282A1 · Jaax · 2014 [cited by examiner]
US 20140296737A1 · Parker · 2014 [cited by examiner]
US 20140378941A1 · Su et al. · 2014 [cited by applicant]
US 20150039048A1 · Woods et al. · 2015 [cited by applicant]
US 20150066108A1 · Shi et al. · 2015 [cited by applicant]
US 20150080982A1 · Funderburk · 2015 [cited by applicant]
US 20150088228A1 · Moffitt · 2015 [cited by applicant]
US 20150157861A1 · Aghassian · 2015 [cited by applicant]
US 20150231402A1 · Aghassian · 2015 [cited by applicant]
US 20150360033A1 · Koubeissi et al. · 2015 [cited by applicant]
US 20150360038A1 · Zottola et al. · 2015 [cited by applicant]
US 20160045747A1 · Jiang et al. · 2016 [cited by applicant]
US 20160158565A1 · Lee · 2016 [cited by applicant]
US 20160287126A1 · Parker et al. · 2016 [cited by applicant]
US 20160339251A1 · Kent et al. · 2016 [cited by applicant]
US 20160361542A1 · Kaula et al. · 2016 [cited by applicant]
US 20170120056A1 · Woods et al. · 2017 [cited by applicant]
US 20170189687A1 · Steinke et al. · 2017 [cited by applicant]
US 20170189689A1 · Steinke et al. · 2017 [cited by applicant]
US 20170281959A1 · Serrano Carmona et al. · 2017 [cited by applicant]
US 20170333701A1 · Bradley et al. · 2017 [cited by applicant]
US 20170333715A1 · De Ridder et al. · 2017 [cited by applicant]
US 20180071513A1 · Weiss et al. · 2018 [cited by applicant]
US 20180071520A1 · Weerakoon et al. · 2018 [cited by applicant]
US 20180071527A1 · Feldman et al. · 2018 [cited by applicant]
US 20180110987A1 · Parker · 2018 [cited by applicant]
US 20180132747A1 · Parker et al. · 2018 [cited by applicant]
US 20180133459A1 · Parker et al. · 2018 [cited by applicant]
US 20180140831A1 · Feldman et al. · 2018 [cited by applicant]
US 20180140843A1 · Kent et al. · 2018 [cited by applicant]
US 20180221644A1 · Grill et al. · 2018 [cited by applicant]
US 20190030323A1 · Koka et al. · 2019 [cited by applicant]
US 20190038902A1 · Kaemmerer et al. · 2019 [cited by applicant]
US 20190070418A1 · Hincapie Ordonez et al. · 2019 [cited by applicant]
US 20190076645A1 · Bower et al. · 2019 [cited by applicant]
US 20190083796A1 · Weerakoon et al. · 2019 [cited by applicant]
US 20190099602A1 · Esteller et al. · 2019 [cited by applicant]
US 20190143120A1 · Sinclair · 2019 [cited by examiner]
US 20190175915A1 · Brill et al. · 2019 [cited by applicant]
US 20190209844A1 · Esteller et al. · 2019 [cited by applicant]
US 20190209851A1 · Kothandaraman et al. · 2019 [cited by applicant]
US 20190232062A1 · Falowski · 2019 [cited by applicant]
US 20190262609A1 · Brill et al. · 2019 [cited by applicant]
US 20190274637A1 · Wilson et al. · 2019 [cited by applicant]
US 20190275331A1 · Zhu · 2019 [cited by applicant]
US 20190299006A1 · Marnfeldt · 2019 [cited by applicant]
US 20190366094A1 · Esteller et al. · 2019 [cited by applicant]
US 20190381318A1 · Sinclair et al. · 2019 [cited by applicant]
US 20200001086A1 · Fernandez et al. · 2020 [cited by applicant]
US 20200001091A1 · Marnfeldt · 2020 [cited by applicant]
US 20200038660A1 · Torgerson · 2020 [cited by applicant]
US 20200138324A1 · Sinclair et al. · 2020 [cited by applicant]
US 20200147393A1 · Zhang et al. · 2020 [cited by applicant]
US 20200305744A1 · Weerakoon et al. · 2020 [cited by applicant]
US 20200305745A1 · Wagenbach et al. · 2020 [cited by applicant]
US 20200335221A1 · Fichtinger et al. · 2020 [cited by applicant]
US 20200391037A1 · Grado et al. · 2020 [cited by applicant]
US 20210016091A1 · Parker et al. · 2021 [cited by applicant]
US 20210046322A1 · Zhang et al. · 2021 [cited by applicant]
US 20210121696A1 · Parker et al. · 2021 [cited by applicant]
US 20210236821A1 · Sinclair et al. · 2021 [cited by applicant]
US 20210267523A1 · Donoghue et al. · 2021 [cited by applicant]
US 20210339014A1 · Dinsmoor et al. · 2021 [cited by applicant]
US 20220040486A1 · Moffitt · 2022 [cited by applicant]
US 20220111213A1 · Cassar et al. · 2022 [cited by applicant]
US 20220151535A1 · Parker et al. · 2022 [cited by applicant]
US 20220218995A1 · Block et al. · 2022 [cited by applicant]
US 20220233866A1 · Gururaj et al. · 2022 [cited by applicant]
US 20220266022A1 · Steinke et al. · 2022 [cited by applicant]
US 20220296892A1 · Esteller et al. · 2022 [cited by applicant]
US 20220296893A1 · Steinke et al. · 2022 [cited by applicant]
US 20220339448A1 · Jayakumar et al. · 2022 [cited by applicant]
US 20230023842A1 · Steinke et al. · 2023 [cited by applicant]
US 20230062062A1 · Litvak et al. · 2023 [cited by applicant]
US 20230069981A1 · Isaacson et al. · 2023 [cited by applicant]
US 20230099390A1 · Esteller et al. · 2023 [cited by applicant]
US 20230141183A1 · Moore et al. · 2023 [cited by applicant]
US 20230201597A1 · Haddock et al. · 2023 [cited by applicant]
US 20230271015A1 · Malekmohammadi et al. · 2023 [cited by applicant]
AU 2014351064 · 2019 [cited by applicant]
AU 2019216650 · 2019 [cited by applicant]
CN 107280665A · 2017 [cited by applicant]
EP 3229891 · 2019 [cited by applicant]
WO 2016205231 · 2016 [cited by applicant]
WO 2018008034 · 2018 [cited by applicant]
WO 2018163178 · 2018 [cited by applicant]
WO 2018213872 · 2018 [cited by applicant]
WO 2019070406 · 2019 [cited by applicant]
WO 2019210371 · 2019 [cited by applicant]
WO 2019211314 · 2019 [cited by applicant]
WO 2019217079 · 2019 [cited by applicant]
WO 2020223165 · 2020 [cited by applicant]
WO 2021026151 · 2021 [cited by applicant]
WO 2021080727 · 2021 [cited by applicant]
Zelmann, Rina, et al., “Automatic Optimization of Depth Electrode Trajectory Planning,” Montreal Neurological Institute Neurology and Neurosurgery, CLIP 2013, LNCS 8361, 2014, pp. 99-104. [cited by applicant]
Beriault, Silvain, et al., “A Multi-Modal Approach to Computer-Assisted Deep Brain Stimulation Trajectory Planning,” International Journal of Computer Assisted Radiology and Surgery, 7, 2012, pp. 687-704. [cited by applicant]
Beriault, Silvain, et al., “A Prospective Evaluation of Computer-Assisted Deep Brain Stimulation Trajectory Planning,” Montreal Neurological Institute McConnell Brain Imaging Centre, CLIP 2012, LNCS 7761, 2013, pp. 42-4… [cited by applicant]
Frankemolle, Anneke M.M., “Reversing Cognitive-Motor Impairments in Parkinson's Disease Patients Using a Computational Modelling Approach to Deep Brain Stimulation Programming,” Brain—A Journal of Neurology, 133, 2010, … [cited by applicant]
Gmel, Gerrit E., et al., “A New Biomarker for Closed-Loop Deep Brain Stimulation in the Subthalamic Nucleus for Patients with Parkinson's Disease,” IEEE Biomedical Circuits and Systems Conference (BioCAS) Proceedings, L… [cited by applicant]
Gmel, Gerrit E., et al., “A New Biomarker for Subthalamic Deep Brain Stimulation for Patients with Advanced Parkinson's Disease—A Pilot Study,” J. Neural Eng., 12, 2015, 11 pages. [cited by applicant]
Gmel, Gerrit Eduard, “Evoked Brain Neural Potentials,” Dissertation for the University of New South Wales, Sep. 2016, 231 pages. [cited by applicant]
Kent, Alexander Rafael, et al., “Characterization of Evoked Potentials During Deep Brain Stimulation in the Thalamus,” Dissertation Submitted in the Department of Biomedical Engineering Duke University, 2013, 320 pages. [cited by applicant]
Kent, Alexander R., et al., “Neural Origin of Evoked Potentials During Thalamic Deep Brain Stimulation,” J Neurophysiol, 110, 2013, pp. 826-843. [cited by applicant]
Kent, A.R., et al., “Recording Evoked Potentials During Deep Brain Stimulaton: Development and Validation of Instrumentation to Suppress to Stimulus Artefact,” J Neural Eng., 9(3), Jun. 2012, 30 pages. [cited by applicant]
Kirsch AD, et al., “Anodic Versus Cathodic Neurostimulation of the Subthalamic Nucleus: A Randomized-Controlled Study of Acute Clinical Effects,” Parkinsonism and Related Disorders, 55, 2018, pp. 61-67. [cited by applicant]
Laarne, Paivi, et al., “Accuracy of Two Dipolar Inverse Algorithms Applying Reciprocity for Forward Calculation,” Computers and Biomedical Research, vol. 33, Issue 3, pp. 172-185, Jun. 2000. [cited by applicant]
Moffitt, Michael A., et al., “Electrical Localization of Neural Activity in the Dorsal Horn of the Spinal Cord: A Modeling Study,” Annals of Biomedical Engineering, 32(12), pp. 1694-1709, 2004. [cited by applicant]
Pascual-Marqui, RD, “Standardized Low-Resolution Brain Electromagnetic Tomography (sLORETA): Technical Details,” Methods Find Exp Clin Pharmacol, 24 Suppl D, 5-12. 2002. [cited by applicant]
Sinclair, Nicholas C., et al., “Subthalamic Nucleus Deep Brain Stimulation Evokes Resonant Neural Activity,” Annals of Neurology, 83(5), pp. 1027-1031, May 4, 2018. [cited by applicant]
Sinclair, Nicholas C., et al., “Subthalamic Nucleus Deep Brain Stimulation Evokes Resonant Neural Activity,” Poster, 2019, 1 page. [cited by applicant]
Sinclair, Nicholas C., et al., “Deep Brain Stimulation for Parkinson's Disease Modulates High-Frequency Evoked and Spontaneous Neural Activity,” Neurobiology of Disease, vol. 130, 104522, Oct. 2019. [cited by applicant]
Sinclair, Nicholas C., et al., “On the Neural Basis of Deep Brain Stimulation Evoked Resonant Activity,” Biomed. Phys. Eng. Express, 5, 2019, 9 pages. [cited by applicant]
Sinclair, Nicholas C., et al., “Directional Deep Brain Stimulation Evoked Resonant Neural Activity (ERNA),” Poster, 2020, 1 page. [cited by applicant]
Thevathasan, Wesley, et al., “Tailoring Subthalamic Nucleus Deep Brain Stimulation for Parkinson's Disease Using Evoked Resonant Neural Activity,” Frontiers in Human Neuroscience, vol. 14, Article 71, Feb. 2020, 6 pages. [cited by applicant]
Walker, Harrison, MD, et al., Directional Subthalamic Nucleus DBS for Parkinson's Disease: Year 3 Interim Analyses, UAB Medicine Poster, 2020, 1 page. [cited by applicant]
Wiest, C. et al., “Local Field Potential Activity Dynamics in Response to Deep Brain Stimulation of the Subthalamic Nucleus in Parkinson's Disease,” Neurobiology of Disease, 143, 2020, 15 pages. [cited by applicant]
Wiest, C., et al, “Subthalamic Deep Brain Stimulation Induces Finely-Tuned Gamma Oscillations in the Absence of Levodopa,” Neurobiology of Disease, 152, 105287, 2021, 13 pages. [cited by applicant]
Georgopoulos, Apostolos P., et al., “On the Relations Between the Direction of Two-Dimensional Arm Movements and Cell Discharge in Primate Motor Cortex,” The Journal of Neuroscience, vol. 2, No. 11, pp. 1527-1537, 1982. [cited by applicant]
Hatsopoulos, Nicholas G. et al., “Sensing with the Motor Cortex,” J. Neuron, 72(3), 22 pages, 2011. [cited by applicant]
Shils, Jay, et al., “Motor Evoked Potential Recordings During Segmented DBS—A Feasibility Study,” Oper Neurosurg (Hagerstown), Mar. 15, 2021, 20(4), pp. 419-425. [cited by applicant]
Wiest, C., et al., “Local Field Potential Activity Dynamics in Response to Deep Brain Stimulation of the Subthalamic Nucleus in Parkinson's Disease.” Neurobiology of Disease, 2019, 41 pages. [cited by applicant]
Qian, Xing, et al., “A Method for Removal of Deep Brain Stimulation Artifact From Local Field Potentials,” IEEE Transactions on Neural Systems and Rehabilitation Engineering, vol. 25, No. 12, Dec. 2017, 10 pages. [cited by applicant]